SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 135 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $2,073,357 | -14.0% | 55,040 | +12.3% | 0.00% | 0.0% |
Q1 2024 | $2,412,026 | +25.2% | 49,005 | -7.2% | 0.00% | 0.0% |
Q4 2023 | $1,926,726 | +92.7% | 52,787 | +22.1% | 0.00% | +50.0% |
Q3 2023 | $999,940 | -23.2% | 43,250 | -12.9% | 0.00% | 0.0% |
Q2 2023 | $1,301,639 | +16.2% | 49,643 | +14.0% | 0.00% | 0.0% |
Q1 2023 | $1,120,488 | +13.4% | 43,531 | +14.6% | 0.00% | 0.0% |
Q4 2022 | $988,328 | -6.6% | 37,998 | +2.4% | 0.00% | 0.0% |
Q3 2022 | $1,058,000 | +13.5% | 37,097 | -2.0% | 0.00% | +100.0% |
Q2 2022 | $932,000 | -43.8% | 37,864 | +28.8% | 0.00% | -50.0% |
Q1 2022 | $1,659,000 | -17.8% | 29,392 | -9.8% | 0.00% | 0.0% |
Q4 2021 | $2,019,000 | -0.1% | 32,573 | +2.2% | 0.00% | -33.3% |
Q3 2021 | $2,021,000 | -39.1% | 31,861 | -20.8% | 0.00% | -25.0% |
Q2 2021 | $3,317,000 | +24.4% | 40,248 | +11.1% | 0.00% | 0.0% |
Q1 2021 | $2,666,000 | +1.1% | 36,235 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $2,636,000 | +72.7% | 36,344 | +13.5% | 0.00% | +100.0% |
Q3 2020 | $1,526,000 | +13.7% | 32,013 | +0.2% | 0.00% | 0.0% |
Q2 2020 | $1,342,000 | +220.3% | 31,947 | +105.7% | 0.00% | +100.0% |
Q1 2020 | $419,000 | -31.8% | 15,530 | -2.6% | 0.00% | 0.0% |
Q4 2019 | $614,000 | – | 15,947 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |